Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Pharmaceutical
PrognomiQ has announced a series D financing round of $34 million, led by Seer, bringing the firm’s total funding to over $135 million since its founding in September 2020. 6 November 2024
Pharmaceutical
Syndax Pharmaceuticals has entered into a $350 million royalty funding agreement with Royalty Pharma. 6 November 2024
Biotechnology
A new Seattle-based biotech company has the best endorsement imaginable as it emerges from stealth. Archon Biosciences’ platform, leveraging AI-driven advances in computational protein design, were recognized earlier this month by the awarding of the 2024 Nobel Prize in Chemistry, for its ability to create novel proteins with desired functions. 31 October 2024
Biotechnology
Boston, USA-based biotech Axonis Therapeutics, which is focused on the development of novel neuromedicines, has announced the successful completion of an oversubscribed $115 million Series A financing. 31 October 2024
Pharmaceutical
Just six months after raising $150 million in an upsized series E financing, cardiometabolic specialist Carmot Therapeutics has filed for an initial public offering (IPO). 21 November 2023
Pharmaceutical
Contract manufacturing organization (CMO) and sterile injectable specialist Torbay Pharmaceuticals has received an investment from private equity firm NorthEdge. 21 November 2023
Biotechnology
A reverse merger will see two Massachusetts, USA-based companies, Q32 Bio and Homology Medicines, joining forces to focus on the former’s autoimmune and inflammatory disease candidates. 20 November 2023
Biotechnology
A new cell therapy company has launched in Cambridge, UK, with $59 million in series A funding provided by Sofinnova Partners and others, including Sanofi Ventures. 16 November 2023
Biotechnology
Dutch biotech company VectorY Therapeutics today announced the close of a 129 million-euro ($138 million) Series A financing. 13 November 2023
Biotechnology
WuXi XDC has published a prospectus for its upcoming initial public offering (IPO), detailing plans to raise $470 million with a listing on the Hong Kong Stock Exchange. 9 November 2023
Biotechnology
East Coast, USA-based biotech incubator Flagship Pioneering is expanding into the Asia-Pacific, with a new regional hub in Singapore. 8 November 2023
Biotechnology
San Mateo, USA-based biotech start-up Cargo Therapeutics, which is specializing in cancer treatments, set terms for its initial public offering (IPO) early Monday with plans to offer 18.8 million shares priced at $15 to $17 each. 7 November 2023
Pharmaceutical
During 2022, investments in research and development in Sweden continued. 6 November 2023
Biotechnology
Lexeo Therapeutics has announced the final pricing of its initial public offering of 9,090,910 shares of common stock at a price to the public of $11.00 per share. 3 November 2023
Biotechnology
Indian contract development and manufacturing organization (CDMO) Aragen is to build a new biologics manufacturing facility in Bangalore. 2 November 2023
Pharmaceutical
A new first-in-class antibiotic, zoliflodacin, has been shown to be effective in the treatment of gonorrhea, in a Phase III trial. 2 November 2023
Biotechnology
French biotech Cellectis saw its shares rocket 149% to 2.24 euros by mid-afternoon trading today, on news of a collaboration an investment deal with UK pharm major AstraZeneca. 1 November 2023
Biotechnology
French pharma major Sanofi is to buy $30 million of shares in MeiraGTx Holdings at a price of $7.50 per share. 30 October 2023
Biotechnology
UK-based investor Abingworth has raised $356 million for a new fund focused on clinical co-development in the life sciences. 30 October 2023
Biotechnology
French venture capital firm Sofinnova Partners has announced the closing of a $200 million fund, spearheaded by partners Edward Kliphuis and Simon Turner. 27 October 2023
Biosimilars
Sandoz, the generic and biosimilar medicines business of Swiss pharma giant Novartis that was fully spun out on October 4, announced the issuance of two highly successful inaugural CHF bonds with gross proceeds of 750 million francs ($843 million). 27 October 2023
Biotechnology
Norway’s clinical-stage biopharmaceutical company Nykode Therapeutics today announced that its private placement has been successfully placed, raising around 505 million Norwegian kroner (~$45 million) in gross proceeds through the allocation of 29,549,400 new shares at a subscription price of 17.10 kroner per share. 25 October 2023
Pharmaceutical
French biotech Abivax has completed an initial public offering (IPO), listing on the Nasdaq global market with 20,325,500 new ordinary shares being issued. 25 October 2023
Biotechnology
American critical care specialist Citius Pharma is to list its oncology subsidiary on the Nasdaq exchange, via merger with a special purpose acquisition company (SPAC). 25 October 2023
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze